AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive?

insidermonkey.com · 2026-10-16

AbbVie Inc. (NYSE:ABBV) is delivering strong returns this year, with shares surging by over 23% year-to-date. In comparison, the broader market has returned nearly 13% in the same period.

TickrTrends take: AbbVie's market outperformance this year contrasts with TickrTrends' assessment that the stock is currently overvalued in the Healthcare sector. A valuation-focused investor should monitor whether the company's operational gains can justify maintaining its current multiple or whether mean reversion pressures may emerge. The gap between stock price momentum and valuation metrics represents a key tension worth tracking for potential shifts in the investment case.

Read the full story at insidermonkey.com →